The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global kidney/renal function test market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.
A kidney/renal function test is performed to diagnose and analyze defects in the overall functioning of the kidney. It relies on blood or urine samples to ensure that the kidney is filtering waste products. Some of the common symptoms of kidney-related problems include blood in urine, swelling in hands or feet and difficulty in urination due to a significant increase in body fluids. Nowadays, a kidney/renal function test can also be suggested by doctors if a patient is suffering from conditions that can impact the kidneys.
The rising prevalence of chronic kidney diseases (CKD) and acute kidney injury (AKI) represents one of the key factors driving the kidney/renal function test market growth. This can be accredited to changing lifestyles, increasing consumption of alcohol and the growing number of individuals suffering from hypertension and diabetes. Apart from this, key players are investing in research and development (R&D) activities for introducing advanced testing products that provide early and efficient disease diagnosis. In addition, increasing healthcare expenditure and the presence of well-established healthcare infrastructure are also contributing to the market growth. Furthermore, public and private health organizations are undertaking numerous initiatives to spread awareness about kidney-related diseases and available disease testing facilities. For instance, in the United States, the National Kidney Foundation (NKF) collaborated with the National Committee for Quality Assurance (NCQA) to introduce a new kidney health evaluation measure, especially for patients with diabetes.
IMARC Group provides an analysis of the key trends in each sub-segment of the global kidney/renal function test market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on test type, product and end use.
Breakup by Test Type:
Breakup by Product:
Breakup by End Use:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 77 Elektronika Kft, Abbott Laboratories, ACON Laboratories Inc., ARKRAY Inc., Beckman Coulter Inc. (Danaher Corporation), F. Hoffmann-La Roche AG, Laboratory Corporation of America Holdings (LabCorp), Nova Biomedical, Quest Diagnostics, Randox Laboratories Ltd., Siemens Healthineers AG and Sysmex Corporation.
|Base Year of the Analysis||2020|
|Segment Coverage||Test Type, Product, End Use, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||77 Elektronika Kft, Abbott Laboratories, ACON Laboratories Inc., ARKRAY Inc., Beckman Coulter Inc. (Danaher Corporation), F. Hoffmann-La Roche AG, Laboratory Corporation of America Holdings (LabCorp), Nova Biomedical, Quest Diagnostics, Randox Laboratories Ltd., Siemens Healthineers AG and Sysmex Corporation.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at